BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 21845079)

  • 1. Controlled delivery of gentamicin using poly(3-hydroxybutyrate) microspheres.
    Francis L; Meng D; Knowles J; Keshavarz T; Boccaccini AR; Roy I
    Int J Mol Sci; 2011; 12(7):4294-314. PubMed ID: 21845079
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Controlled Delivery of Pan-PAD-Inhibitor Cl-Amidine Using Poly(3-Hydroxybutyrate) Microspheres.
    Ahmed D; Puthussery H; Basnett P; Knowles JC; Lange S; Roy I
    Int J Mol Sci; 2021 Nov; 22(23):. PubMed ID: 34884657
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Multi-functional P(3HB) microsphere/45S5 Bioglass-based composite scaffolds for bone tissue engineering.
    Francis L; Meng D; Knowles JC; Roy I; Boccaccini AR
    Acta Biomater; 2010 Jul; 6(7):2773-86. PubMed ID: 20056174
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Poly(hydroxybutyrate-hydroxyvalerate) microspheres containing progesterone: preparation, morphology and release properties.
    Gangrade N; Price JC
    J Microencapsul; 1991; 8(2):185-202. PubMed ID: 1765899
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Preparation and characterization of negatively charged poly(lactic-co-glycolic acid) microspheres.
    Xu Q; Crossley A; Czernuszka J
    J Pharm Sci; 2009 Jul; 98(7):2377-89. PubMed ID: 19009589
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An experimental design approach to the preparation of pegylated polylactide-co-glicolide gentamicin loaded microparticles for local antibiotic delivery.
    Dorati R; DeTrizio A; Genta I; Grisoli P; Merelli A; Tomasi C; Conti B
    Mater Sci Eng C Mater Biol Appl; 2016 Jan; 58():909-17. PubMed ID: 26478386
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Gentamicin encapsulation in PLA/PLGA microspheres in view of treating Brucella infections.
    Prior S; Gamazo C; Irache JM; Merkle HP; Gander B
    Int J Pharm; 2000 Feb; 196(1):115-25. PubMed ID: 10675713
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of impeller speed and pH on the production of poly(3-hydroxybutyrate) using Bacillus cereus SPV.
    Philip S; Sengupta S; Keshavarz T; Roy I
    Biomacromolecules; 2009 Apr; 10(4):691-9. PubMed ID: 19296657
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Microencapsulation of ovalbumin in poly(lactide-co-glycolide) by an oil-in-oil (o/o) solvent evaporation method.
    Uchida T; Yagi A; Oda Y; Goto S
    J Microencapsul; 1996; 13(5):509-18. PubMed ID: 8864988
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Carriers based on poly-3-hydroxyalkanoates containing nanomagnetite to trigger hormone release.
    de Freitas E Castro M; Mendonça TT; da Silva LF; Gomez JGC; Sanchez Rodriguez RJ
    Int J Biol Macromol; 2021 Jan; 166():448-458. PubMed ID: 33127545
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of salt addition on the microencapsulation of proteins using W/O/W double emulsion technique.
    Pistel KF; Kissel T
    J Microencapsul; 2000; 17(4):467-83. PubMed ID: 10898087
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Enhanced gentamicin loading and release of PLGA and PLHMGA microspheres by varying the formulation parameters.
    Chaisri W; Ghassemi AH; Hennink WE; Okonogi S
    Colloids Surf B Biointerfaces; 2011 Jun; 84(2):508-14. PubMed ID: 21353499
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of nanoscale and microscale bioactive glass on the properties of P(3HB)/Bioglass composites.
    Misra SK; Mohn D; Brunner TJ; Stark WJ; Philip SE; Roy I; Salih V; Knowles JC; Boccaccini AR
    Biomaterials; 2008 Apr; 29(12):1750-61. PubMed ID: 18255139
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Preparation of biodegradable microspheres and matrix devices containing naltrexone.
    Dinarvand R; Moghadam SH; Mohammadyari-Fard L; Atyabi F
    AAPS PharmSciTech; 2003; 4(3):E34. PubMed ID: 14621966
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lappaconitine-loaded microspheres for parenteral sustained release: effects of formulation variables and in vitro characterization.
    Xu H; Zhong H; Liu M; Xu C; Gao Y
    Pharmazie; 2011 Sep; 66(9):654-61. PubMed ID: 22026119
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Preparation, characterization and in vitro release of gentamicin from PHBV/wollastonite composite microspheres.
    Li H; Chang J
    J Control Release; 2005 Oct; 107(3):463-73. PubMed ID: 16154657
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Preparation and characterization of hCG-loaded polylactide or poly(lactide-co-glycolide) microspheres using a modified water-in-oil-in-water (w/o/w) emulsion solvent evaporation technique.
    Zhu KJ; Jiang HL; Du XY; Wang J; Xu WX; Liu SF
    J Microencapsul; 2001; 18(2):247-60. PubMed ID: 11253941
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Preparation and characterization of PHBV microsphere/45S5 bioactive glass composite scaffolds with vancomycin releasing function.
    Li W; Ding Y; Rai R; Roether JA; Schubert DW; Boccaccini AR
    Mater Sci Eng C Mater Biol Appl; 2014 Aug; 41():320-8. PubMed ID: 24907766
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Microsphere delivery of Risperidone as an alternative to combination therapy.
    D'Souza S; Faraj J; DeLuca P
    Eur J Pharm Biopharm; 2013 Nov; 85(3 Pt A):631-9. PubMed ID: 23892159
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effect of formulation variables on the characteristics of insulin-loaded poly(lactic-co-glycolic acid) microspheres prepared by a single phase oil in oil solvent evaporation method.
    Hamishehkar H; Emami J; Najafabadi AR; Gilani K; Minaiyan M; Mahdavi H; Nokhodchi A
    Colloids Surf B Biointerfaces; 2009 Nov; 74(1):340-9. PubMed ID: 19717287
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.